Form 4: SVP at Soleno Therapeutics Sells Shares to Cover Tax Obligations
SEC Form 4
Kristen Yen, SVP at Soleno Therapeutics, reports selling shares of common stock to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On March 27, 2025, Kristen Yen, SVP at Soleno Therapeutics, executed multiple transactions involving the company's common stock.
- Yen sold a total of 97,409 shares at prices ranging from $65.15 to $72.80.
- These sales were primarily to cover tax withholding obligations related to the vesting of restricted stock units (RSUs).
- Additionally, Yen exercised options to acquire 4,888 shares at $5.10, 3,750 shares at $2.41 and 32,000 shares at $5.25.
- Following these transactions, Yen directly owns 51,618 shares of common stock and holds options for 69,445 shares.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by an officer. It doesn't inherently convey positive or negative sentiment, as it's a factual report of trading activity.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company executives.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the increased supply of shares in the market, but the impact is likely minimal given the relatively small volume of shares sold compared to the total outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 01/01/2022 | Vesting Commencement Date for some stock options. |
| 01/25/2023 | Vesting Commencement Date for some stock options. |
| 05/26/2023 | Vesting Commencement Date for some stock options. |
| 03/27/2025 | Date of the reported transactions: stock sales and option exercises. |
| 03/31/2025 | Date of the signature on the Form 4 filing. |
| 01/28/2032 | Expiration date for some stock options. |
| 01/25/2033 | Expiration date for some stock options. |
| 05/26/2033 | Expiration date for some stock options. |
Keywords
Form 4, Insider Trading, Stock Options, Restricted Stock Units, Common Stock, Soleno Therapeutics, SLNO, Kristen Yen
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.